Cargando…

The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility

BACKGROUND AND AIMS: Peripheral neuropathy is a common diabetic complication. It is linked to poor glycaemic control and longer duration of diabetes. We explored the association between HbA1c and neuropathy risk considering the duration of diabetes in a sample of Saudi diabetic patients. METHOD: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfaez, Saad M., Alsalmi, Thekra I., Alfeer, Raghad N., Alghamdi, Elaf K., Alzahrani, Mohammed Ali, Al Bogami, Safar A., Mubarak, Ali S., Alshehri, Khalid M., Alfadhly, Abulaziz F., AlMalki, Basim M., Alosaimi, Jawhara A., Alzahrani, Fahad M., Al-Ghamdi, Abdullah, Osman, Mugtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254814/
https://www.ncbi.nlm.nih.gov/pubmed/35800515
http://dx.doi.org/10.4103/jfmpc.jfmpc_1362_21
_version_ 1784740787673628672
author Alfaez, Saad M.
Alsalmi, Thekra I.
Alfeer, Raghad N.
Alghamdi, Elaf K.
Alzahrani, Mohammed Ali
Al Bogami, Safar A.
Mubarak, Ali S.
Alshehri, Khalid M.
Alfadhly, Abulaziz F.
AlMalki, Basim M.
Alosaimi, Jawhara A.
Alzahrani, Fahad M.
Al-Ghamdi, Abdullah
Osman, Mugtaba
author_facet Alfaez, Saad M.
Alsalmi, Thekra I.
Alfeer, Raghad N.
Alghamdi, Elaf K.
Alzahrani, Mohammed Ali
Al Bogami, Safar A.
Mubarak, Ali S.
Alshehri, Khalid M.
Alfadhly, Abulaziz F.
AlMalki, Basim M.
Alosaimi, Jawhara A.
Alzahrani, Fahad M.
Al-Ghamdi, Abdullah
Osman, Mugtaba
author_sort Alfaez, Saad M.
collection PubMed
description BACKGROUND AND AIMS: Peripheral neuropathy is a common diabetic complication. It is linked to poor glycaemic control and longer duration of diabetes. We explored the association between HbA1c and neuropathy risk considering the duration of diabetes in a sample of Saudi diabetic patients. METHOD: We conducted a monofilament test on 343 diabetic patients referred to our specialist diabetology centre in Saudi Arabia. We utilized a multiple generalized logistic regression model with a binary outcome related to neuropathy complications. RESULTS: We found that over four out of every five patients have peripheral neuropathy. The interaction between HbA1c and duration was significant (estimate = −0.02802, P = 0.00534), a positive association between neuropathy and both HbA1c (increased risk by 46.2%, P = 0.03222) and DM duration (increased risk by 19.6%, P = 0.04497). CONCLUSIONS: The shorter the duration of diabetes, the more positive the relationship between HbA1c and peripheral neuropathy. In patients living for over 40 years with diabetes, HbA1c was higher among those who did not have peripheral neuropathy. It could be argued that this is an artefact of survival as poorer glycaemic control will likely result in higher mortality in earlier years of the diabetes career.
format Online
Article
Text
id pubmed-9254814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-92548142022-07-06 The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility Alfaez, Saad M. Alsalmi, Thekra I. Alfeer, Raghad N. Alghamdi, Elaf K. Alzahrani, Mohammed Ali Al Bogami, Safar A. Mubarak, Ali S. Alshehri, Khalid M. Alfadhly, Abulaziz F. AlMalki, Basim M. Alosaimi, Jawhara A. Alzahrani, Fahad M. Al-Ghamdi, Abdullah Osman, Mugtaba J Family Med Prim Care Original Article BACKGROUND AND AIMS: Peripheral neuropathy is a common diabetic complication. It is linked to poor glycaemic control and longer duration of diabetes. We explored the association between HbA1c and neuropathy risk considering the duration of diabetes in a sample of Saudi diabetic patients. METHOD: We conducted a monofilament test on 343 diabetic patients referred to our specialist diabetology centre in Saudi Arabia. We utilized a multiple generalized logistic regression model with a binary outcome related to neuropathy complications. RESULTS: We found that over four out of every five patients have peripheral neuropathy. The interaction between HbA1c and duration was significant (estimate = −0.02802, P = 0.00534), a positive association between neuropathy and both HbA1c (increased risk by 46.2%, P = 0.03222) and DM duration (increased risk by 19.6%, P = 0.04497). CONCLUSIONS: The shorter the duration of diabetes, the more positive the relationship between HbA1c and peripheral neuropathy. In patients living for over 40 years with diabetes, HbA1c was higher among those who did not have peripheral neuropathy. It could be argued that this is an artefact of survival as poorer glycaemic control will likely result in higher mortality in earlier years of the diabetes career. Wolters Kluwer - Medknow 2022-05 2022-05-14 /pmc/articles/PMC9254814/ /pubmed/35800515 http://dx.doi.org/10.4103/jfmpc.jfmpc_1362_21 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Alfaez, Saad M.
Alsalmi, Thekra I.
Alfeer, Raghad N.
Alghamdi, Elaf K.
Alzahrani, Mohammed Ali
Al Bogami, Safar A.
Mubarak, Ali S.
Alshehri, Khalid M.
Alfadhly, Abulaziz F.
AlMalki, Basim M.
Alosaimi, Jawhara A.
Alzahrani, Fahad M.
Al-Ghamdi, Abdullah
Osman, Mugtaba
The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility
title The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility
title_full The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility
title_fullStr The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility
title_full_unstemmed The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility
title_short The changeable dynamics between glycaemic control and neuropathy risk across the lifespan of Saudi diabetic patients; A survey in diabetes healthcare facility
title_sort changeable dynamics between glycaemic control and neuropathy risk across the lifespan of saudi diabetic patients; a survey in diabetes healthcare facility
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254814/
https://www.ncbi.nlm.nih.gov/pubmed/35800515
http://dx.doi.org/10.4103/jfmpc.jfmpc_1362_21
work_keys_str_mv AT alfaezsaadm thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alsalmithekrai thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alfeerraghadn thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alghamdielafk thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alzahranimohammedali thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT albogamisafara thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT mubarakalis thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alshehrikhalidm thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alfadhlyabulazizf thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT almalkibasimm thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alosaimijawharaa thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alzahranifahadm thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alghamdiabdullah thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT osmanmugtaba thechangeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alfaezsaadm changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alsalmithekrai changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alfeerraghadn changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alghamdielafk changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alzahranimohammedali changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT albogamisafara changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT mubarakalis changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alshehrikhalidm changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alfadhlyabulazizf changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT almalkibasimm changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alosaimijawharaa changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alzahranifahadm changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT alghamdiabdullah changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility
AT osmanmugtaba changeabledynamicsbetweenglycaemiccontrolandneuropathyriskacrossthelifespanofsaudidiabeticpatientsasurveyindiabeteshealthcarefacility